Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous bone marrow mononuclear cell transplantation for systemic sclerosis skin ulcers
jRCTb032210204Recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Jul 2021
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of autologous bone marrow-derived mononuclear cell in systemic sclerosis (SSc), sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Effective treatment rate. Started Jul 2021; status: recruiting.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on jRCTb032210204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTb032210204.